What’s Broken in Audience Targeting - And How to Fix It
The one constant in healthcare marketing is change, particularly in four key areas: Evolving...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists...
The one constant in healthcare marketing is change, particularly in four key areas: Evolving...
In the evolving world of real-world data (RWD), pharmaceutical companies are increasingly focused...
In our series exploring the benefits, considerations and use cases for various types of real-world...
Background of the CRWDi project While the COVID-19 pandemic is behind us, the virus remains a...
The healthcare industry has moved away from paper charts and file folders in favor of electronic...
Part 4: Indirect and qualitative metrics for matching accuracy [Part 4] of Matching Accuracy...
As high-value therapies become the new norm,life sciences teams need closed claims data that...
HealthVerity COO Andrew Goldberg recently sat down with Quest Diagnostics’ Director, Health...
Open claims and closed payer claims data are essential for understanding the status and activities...
The FDA often requires some sort of post-market surveillance for medical devices to determine the...
Human papillomavirus (HPV) is one of the most common sexually transmitted infections in the United States. Almost all sexually active individuals are exposed to HPV at some point in their lifetime. Although most infections are asymptomatic and self-l...